Christine Lundgren

Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up

Christine Lundgren, Pär‐Ola Bendahl, Maria Ekholm et al. · Breast Cancer Research · 2020 · 74 citations · Full text

Medicine, Immunology, Oncology +14

Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer

Christine Lundgren, Pär‐Ola Bendahl, Åke Borg et al. · Breast Cancer Research and Treatment · 2019 · 32 citations · Full text

Medicine, Oncology, Pathology +17

PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients

Christine Lundgren, Pär‐Ola Bendahl, S. Church et al. · npj Breast Cancer · 2022 · 26 citations · Full text

Medicine, Oncology, Breast Oncology +14

Good adherence to adjuvant endocrine therapy in early breast cancer – a population-based study based on the Swedish Prescribed Drug Register

Christine Lundgren, Henrik Lindman, Bo Rolander et al. · Acta Oncologica · 2018 · 25 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter Study

Una Kjällquist, Balázs Ács, Sara Margolin et al. · Cancers · 2022 · 21 citations · Full text

Medicine, Oncology, Breast Oncology +16